abstract |
The present invention discloses a method for treating HBV infection or HBV/HDV co-infection, said method comprising administering to a subject in need of treatment a first pharmaceutically acceptable agent for removing hepatitis B surface antigen from blood and a second pharmaceutically acceptable agent that stimulates immune function. |